IRIS
SCUDERI, Sarah Adriana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 526
EU - Europa 465
AS - Asia 64
Totale 1.055
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 526
IE - Irlanda 204
SE - Svezia 139
IT - Italia 79
SG - Singapore 21
CN - Cina 13
IN - India 12
FR - Francia 10
FI - Finlandia 7
TW - Taiwan 7
NL - Olanda 6
BE - Belgio 5
DE - Germania 4
IR - Iran 3
JP - Giappone 3
ES - Italia 2
HK - Hong Kong 2
IQ - Iraq 2
NO - Norvegia 2
PL - Polonia 2
UA - Ucraina 2
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
PK - Pakistan 1
Totale 1.055
Salva come PNG Salva come JPEG
Città #
Dublin 204
Chandler 188
Nyköping 124
Ashburn 55
New York 31
Princeton 26
Boardman 19
Medford 19
Messina 16
Singapore 14
Des Moines 13
Rome 8
Gentilly 7
Pune 6
Wilmington 6
Brussels 5
Falls Church 5
Yuanlin 5
Cagliari 4
Helsinki 4
Hyderabad 4
Washington 4
Canicattini Bagni 3
Catania 3
Corigliano Calabro 3
Paternò 3
Turin 3
Wakayama 3
Alba 2
Alicante 2
Baghdad 2
Columbus 2
Drammen 2
Florence 2
Gallarate 2
Hong Kong 2
Kaohsiung City 2
Lappeenranta 2
Los Angeles 2
Mumbai 2
Naaldwijk 2
Nanjing 2
Ostiano 2
Paris 2
Ragusa 2
Reggio Calabria 2
Solarino 2
Tappahannock 2
Tianjin 2
Amsterdam 1
Bremen 1
Brno 1
Cambridge 1
Chieti 1
Fuzhou 1
Germering 1
Hamburg 1
Hangzhou 1
Hebei 1
Jinan 1
Kyiv 1
Lugo 1
Mantova 1
Napoli 1
Norwalk 1
Peshawar 1
Piazza Armerina 1
Qingdao 1
Rozendaal 1
Taizhou 1
Taranto 1
Torre del Greco 1
Warsaw 1
Zhengzhou 1
Totale 852
Salva come PNG Salva come JPEG
Nome #
Influence of coagulase-negative staphylococci as potential probiotics on Dry Eye 74
Stafilococchi coagulasi-negativi potenziali probiotici per il Dry Eye 57
Evaluation of a Product Containing Xyloglucan and Pea Protein on Skin Barrier Permeability 55
Co-ultra PEALut enhances endogenous repair response following moderate traumatic brain injury 49
Modulation of NLRP3 inflammasome attenuated inflammatory response associated to diarrhea-predominant irritable bowel syndrome 49
Role of fibroblast growth factors receptors (FGFRs) in brain tumors, focus on astrocytoma and glioblastoma 46
KYP-2047, an inhibitor of prolyl-oligopeptidase, reduces glioblastoma proliferation through angiogenesis and apoptosis modulation 46
The inhibition of prolyl oligopeptidase as new target to counteract chronic venous insufficiency: Findings in a mouse model 45
Therapeutic potential of flavonoids in the treatment of chronic venous insufficiency 44
Involvement of TBK1 and PREP signalling pathways in Glioblastoma Multiforme progression: novel therapeutic perspectives 42
Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma 42
Antioxidant and anti-inflammatory effect of nrf2 inducer dimethyl fumarate in neurodegenerative diseases 40
The protective role of prolyl oligopeptidase (pop) inhibition in acute lung injury induced by intestinal ischemia-reperfusion 40
Poly (Adp-ribose) polymerase inhibitor, abt888, improved cisplatin effect in human oral cell carcinoma 40
Role of ABT888, a Novel Poly(ADP-Ribose) Polymerase (PARP) Inhibitor in Countering Autophagy and Apoptotic Processes Associated to Spinal Cord Injury 39
Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model 39
Synergic therapeutic potential of PEA-Um treatment and NAAA enzyme silencing in the management of neuroinflammation 36
NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression 35
The inhibition of mammalian target of rapamycin (mTOR) in improving inflammatory response after traumatic brain injury 33
TBK1 Inhibitor Exerts Antiproliferative Effect on Glioblastoma Multiforme Cells 30
Effect of Melatonin on Psoriatic Phenotype in Human Reconstructed Skin Model 27
Ulva pertusa, a Marine Green Alga, Attenuates DNBS-Induced Colitis Damage via NF-κB/Nrf2/SIRT1 Signaling Pathways 25
Pea-oxa mitigates oxaliplatin-induced painful neuropathy through nf-κb/nrf-2 axis 25
GSK343, an Inhibitor of Enhancer of Zeste Homolog 2, Reduces Glioblastoma Progression through Inflammatory Process Modulation: Focus on Canonical and Non-Canonical NF-κB/IκBα Pathways 25
BAY-117082-driven NLRP3 inflammasome inhibition resolves nitro-glycerine (NTG) neuronal damage in in vivo model of migraine 22
The Biological Function of MicroRNAs in Bone Tumors 20
Supplementation with SCFAs Re-Establishes Microbiota Composition and Attenuates Hyperalgesia and Pain in a Mouse Model of NTG-Induced Migraine 18
Sodium Propionate Contributes to Tumor Cell Growth Inhibition through PPAR-γ Signaling 17
Evaluation of the Efficacy of Xyloglucan, Pea Protein and Opuntia ficus-indica Extract in a Preclinical Model of Psoriasis 15
null 15
Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC) 10
Effect of a combination of pea protein, grape seed extract and lactic acid in an in vivo model of bacterial vaginosis 7
Neuroprotective effects of GSK-343 in an in vivo model of MPTP-induced nigrostriatal degeneration 6
Pentraxin 3: A Main Driver of Inflammation and Immune System Dysfunction in the Tumor Microenvironment of Glioblastoma 3
Potential preventive role of probiotics against Pseudomonas aeruginosa corneal infection 2
The Impact of COVID-19 on Amputation and Mortality Rates in Patients with Acute Limb Ischemia: A Systematic Review and Meta-Analysis 1
Synergistic Effect of Plant Compounds in Combination with Conventional Antimicrobials against Biofilm of Staphylococcus aureus, Pseudomonas aeruginosa, and Candida spp 1
Totale 1.120
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.954
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.954
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 0 9 10 6 0 1 1
2021/2022181 0 6 10 12 16 4 7 5 16 3 29 73
2022/2023631 50 62 29 49 42 67 6 37 253 9 22 5
2023/2024238 7 27 9 18 28 77 11 12 0 9 4 36
2024/202543 43 0 0 0 0 0 0 0 0 0 0 0
Totale 1.120